Home / Letter From The Editor / Letter from the Editor, #790

Letter from the Editor, #790

Jul 12, 2015

Last Monday night I was delivering a CE on MTM and Med Errors to a group of pharmacists in Tampa. As I was delving into the reasons for MTM (Medication Therapy Management), I was enlightening the younger pharmacists on ways that our profession has changed over the past 30 years. One of the things that came to light was the idea of how the Cytochrome P450 affects prescribing habits and potential drug interactions and how when I went to pharmacy school we had never heard of that. One of the younger pharmacists brought up the topic of pharmacogenomics and how this was bound to impact disease occurrence and medication use even more than Cytochrome P450 in the future.

This week we have some of the latest research on how genes and DNA can be affected by disease and medication. Item #1 looks at the effect of rapid changes in ancestral diets without time to adjust genomicly. Item #4 compares the DNA and genomic learning curves of humans and blind cavefish, and Item #5 has valuable information as to how variation in genomic results can influence drug utilization and effectiveness.




dLifeTV.com: Sunday, July 19, 7PM ET

From dLife.com: "dLife explores care giving – the challenges, and the rewards. Plus, Nicole Johnson pays a visit to the research labs of the NIDDK to see the search for a cure in progress. And, a college basketball coach who didn’t let a diabetes severe complication, keep him from a championship season." Sundays live online at dLifeTV.com at 7 PM ET, 6 PM CT, and 4 PM PT. Keep up on the latest dLife news at dLifeTV.com.

#DiabetesChat for your patients: "On July 22, from 8-9 p.m. ET, please join the next #DiabetesChat with co-host Dr. Karin Hehenberger, M.D., Ph.D. and founder of LyfeBulb. Dr. Hehenberger will be discussing the topic of "Diabetes and Living: 10 Things You Need to Know" and we will be giving away 10 Copies of Dr. Karin Hehenberger’s book "Ten Things You Need to Know about Living with Diabetes." Follow @Lyfebulb & @DiabetesInCntrl."

We can make a difference!


Dave Joffe, Editor-in-chief